Preadmission predictors of severe COVID-19 in patients with diabetes mellitus.

TitlePreadmission predictors of severe COVID-19 in patients with diabetes mellitus.
Publication TypeJournal Article
Year of Publication2021
AuthorsShukla AP, Tchang BG, Lam T, Steller I, Touhamy S, Askin G, Curanaj FAMendelso, Seley JJ, Lorber D, Safford MM, Aronne LJ, Alonso LC
JournalJ Diabetes Complications
Volume35
Issue8
Pagination107967
Date Published2021 08
ISSN1873-460X
KeywordsAdult, Aged, Aged, 80 and over, Body Mass Index, Comorbidity, Continental Population Groups, COVID-19, Diabetes Mellitus, Type 2, Female, Humans, Intensive Care Units, Male, Middle Aged, New York, Obesity, Patient Admission, Prognosis, Retrospective Studies, Risk Factors, SARS-CoV-2, Severity of Illness Index
Abstract

OBJECTIVE: To explore predictors of severe COVID-19 disease in patients with diabetes hospitalized for COVID-19.

METHODS: This is a retrospective observational study of adults with diabetes admitted for COVID-19. Bivariate tests and multivariable Cox regression were used to identify risk factors for severe COVID-19, defined as a composite endpoint of intensive care unit admission/intubation or in-hospital death.

RESULTS: In 1134 patients with diabetes admitted for COVID-19, more severe disease was associated with older age (HR 1.02, p<0.001), male sex (HR 1.28, p=0.017), Asian race (HR 1.34, p=0.029 [reference: white]), and greater obesity (moderate obesity HR 1.59, p=0.015; severe obesity HR 2.07, p=0.002 [reference: normal body mass index]). Outpatient diabetes medications were not associated with outcomes.

CONCLUSIONS: Age, male sex, Asian race, and obesity were associated with increased risk of severe COVID-19 disease in adults with type 2 diabetes hospitalized for COVID-19.

SUMMARY: In patients with type 2 diabetes hospitalized for COVID-19 disease, we observed that age, male sex, Asian race, and obesity predicted severe COVID-19 outcomes of intensive care unit admission, intubation, or in-hospital death. The risk conferred by obesity increased with worsening obesity. Outpatient diabetes medications were not observed to be significant predictors of study outcomes.

DOI10.1016/j.jdiacomp.2021.107967
Alternate JournalJ Diabetes Complications
PubMed ID34099384
PubMed Central IDPMC8162023
Grant ListUL1 TR002384 / TR / NCATS NIH HHS / United States